CAROLYN KALLMEYER: Open Payments
NPI 1265734370 · FT MITCHELL, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 12 payments from 9 companies in 2025. Trend: 2023 $686 · 2024 $1,168 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $242 |
| Lilly USA, LLC | 2 | $236 |
| Amgen Inc. | 1 | $148 |
| Gilead Sciences, Inc. | 1 | $122 |
| Kowa Pharmaceuticals America, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| ABBVIE INC. | 1 | $117 |
| Neurelis, Inc. | 2 | $83 |
Products named: Wegovy, REPATHA, Yeztugo, ZORYVE, Auvelity, Kerendia, QULIPTA, ZEPBOUND.
Industry payments across KY — which companies pay providers there.
